122 related articles for article (PubMed ID: 26896489)
1. The repair capacity of lung cancer cell lines A549 and H1299 depends on HMGB1 expression level and the p53 status.
Yusein-Myashkova S; Stoykov I; Gospodinov A; Ugrinova I; Pasheva E
J Biochem; 2016 Jul; 160(1):37-47. PubMed ID: 26896489
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.
Zheng H; Chen JN; Yu X; Jiang P; Yuan L; Shen HS; Zhao LH; Chen PF; Yang M
DNA Cell Biol; 2016 Oct; 35(10):622-627. PubMed ID: 27383136
[TBL] [Abstract][Full Text] [Related]
3. Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro.
Ugrinova I; Zlateva S; Pashev IG; Pasheva EA
Int J Biochem Cell Biol; 2009 Jul; 41(7):1556-62. PubMed ID: 19401149
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
6. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
[TBL] [Abstract][Full Text] [Related]
8. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
[TBL] [Abstract][Full Text] [Related]
9. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.
Tsutsumi K; Yasuda M; Nishioka T
Cell Struct Funct; 2006; 31(2):47-52. PubMed ID: 16951535
[TBL] [Abstract][Full Text] [Related]
10. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
Park S; Lippard SJ
Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
[TBL] [Abstract][Full Text] [Related]
11. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
Krynetskaia NF; Phadke MS; Jadhav SH; Krynetskiy EY
Mol Cancer Ther; 2009 Apr; 8(4):864-72. PubMed ID: 19372559
[TBL] [Abstract][Full Text] [Related]
12. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
13. Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer.
Choi JH; Ahn KS; Kim J; Hong YS
Exp Mol Med; 2000 Mar; 32(1):23-8. PubMed ID: 10762058
[TBL] [Abstract][Full Text] [Related]
14. Non-histone protein HMGB1 inhibits the repair of damaged DNA by cisplatin in NIH-3T3 murine fibroblasts.
Yusein-Myashkova S; Ugrinova I; Pasheva E
BMB Rep; 2016 Feb; 49(2):99-104. PubMed ID: 24325815
[TBL] [Abstract][Full Text] [Related]
15. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
16. p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells.
Bhana S; Hewer A; Phillips DH; Lloyd DR
Mutagenesis; 2008 Mar; 23(2):131-6. PubMed ID: 18267949
[TBL] [Abstract][Full Text] [Related]
17. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
Chiang HC; Tsou TC
Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.
Branch P; Masson M; Aquilina G; Bignami M; Karran P
Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568
[TBL] [Abstract][Full Text] [Related]
19. Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells.
Tortelli TC; Tamura RE; de Souza Junqueira M; da Silva Mororó J; Bustos SO; Natalino RJM; Russell S; Désaubry L; Strauss BE; Chammas R
Aging (Albany NY); 2021 Sep; 13(18):21914-21940. PubMed ID: 34528900
[TBL] [Abstract][Full Text] [Related]
20. Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells.
Kong L; Murata MM; Digman MA
Biochem Biophys Res Commun; 2018 Jan; 496(1):199-204. PubMed ID: 29307819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
